Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
22. March 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9325
Articles 1 - 20 / 186500
Re: Hiroshi Kitamura, Taiji Tsukamoto, Yoshiyuki Kakehi, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Contieri R, Lazzeri M, Perdonà S, Hurle R.
PMID: 41864760 [PubMed - as supplied by publisher]
Reply to Roberto Contieri, Massimo Lazzeri, Sisto Perdonà , and Rodolfo Hurle's Letter to the Editor re: Kitamura, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008.
Eur Urol
Kitamura H, Nishiyama H.
PMID: 41864759 [PubMed - as supplied by publisher]
Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS multicentric retrospective study.
Int J Radiat Oncol Biol Phys
Anger E, Supiot S, Josset Q, Pasquier D, Vaugier L, Riet FG, Pointreau Y, Ruffier A, Loos G, Terlizzi M, Blanchard P, Martin E, Sargos P, Guerni M, Schick U, Bera G, Roman J, Latorzeff I, Créhange G, Castelli J, Barateau A, De Crevoisier R, Nicosia L, Guévelou JL.
PMID: 41864432 [PubMed - as supplied by publisher]
Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study.
J Am Acad Dermatol
Chen YJ, Liu WT, Yang CC.
PMID: 41864295 [PubMed - as supplied by publisher]
Editorial Comment on "A Practical Phenotyping Framework for Male LUTS Using Remote Multi-Day Urinary Diagnostics".
Urology
Te AE.
PMID: 41864286 [PubMed - as supplied by publisher]
Endothelial SMAD1-MCAM axis facilitates sunitinib resistance and progression of clear cell renal cell carcinoma via LAMB1-ITGB1 signaling.
Drug Resist Updat
Zhang H, Liu Y, Zhang W, Guo Y, Lin A, Jin Y, Lu P, Fang Y, Zhang H, Qu L, Luo P, Wu L, Chen Y, Kang X, Wang L, Jiang A.
PMID: 41864072 [PubMed - as supplied by publisher]
Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.
Urologia
Ilktac A, Dogan B, Gevher F, Akcay M, Akbulut H, Ilbey YO.
PMID: 41863856 [PubMed - as supplied by publisher]
Surgical Management of Bone Metastases in Bladder Cancer: A Single-Center Retrospective Study.
Cancer Rep (Hoboken)
Doumanidis P, Tsagkozis P.
PMID: 41863065 [PubMed - indexed for MEDLINE]
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.
Trials
Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N.
PMID: 41863008 [PubMed - as supplied by publisher]
Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study.
Urol Oncol
Harper A, Khan M, Imm KR, Grubb RL 3rd, Kim EH, Colditz GA, Wolin KY, Kibel AS, Sutcliffe S, Yang L.
PMID: 41862406 [PubMed - as supplied by publisher]
Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective.
Eur Urol Oncol
Duquesne I, Epelbaum I, Prost D, Haberstich M, Suartz CV, Blons H, Taly V, Laurent-Puig P, Horowitz A, Sfakianos JP, Thibault C, Audenet F.
PMID: 41862336 [PubMed - as supplied by publisher]
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14).
Eur Urol Oncol
Gillessen S, Gobat K, Cathomas R, Fischer N, Pereira Mestre R, Hermanns T, Rothschild SI, Mach N, Mingrone W, Ciriolo M, Müller B, Erdmann A, Schär C, Mamot C, Bohanes P, Omlin A, Bastian S, Ribi K, Mazzucchelli L, Barizzi J, Horvath LG, Scheinberg T, Mellor R, Schär S, Lin HM, Lim R, Pollak M, Turco F, Rothermundt C.
PMID: 41862335 [PubMed - as supplied by publisher]
MR ProGradeNet A Multi-Resolution Deep Learning Framework for Automated Prostate Cancer Grading from MRI.
Semin Ultrasound CT MR
Ghag KV, Jagdale J, Vyawahare M.
PMID: 41862143 [PubMed - as supplied by publisher]
Renal cell carcinoma presenting with orbital metastasis as the initial symptom: A case report.
Medicine (Baltimore)
Wang X, Fan Z, Liu R, Qiao Z, Dong W, Shi S, Liu C.
PMID: 41861213 [PubMed - indexed for MEDLINE]
Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain.
PLoS One
Zin CS, Lando S, González-Ortiz A, Mahalingasivam V, Mostafaei S, Ahmad WR, Ahmad Shah MM, Wettermark B, Carrero JJ.
PMID: 41860838 [PubMed - indexed for MEDLINE]
Prognostic value of baseline circulating tumor DNA levels in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.
Front Immunol
Liao Y, Lin Y, Luo B, Shen J.
PMID: 41859077 [PubMed - indexed for MEDLINE]
Active Surveillance for Localized Prostate Cancer: AÂ Retrospective Single-Center Study.
Int J Urol
Sugino A, Miyazawa Y, Nakazawa S, Tsuji Y, Fujizuka Y, Arai S, Sekine Y, Nomura M, Koike H, Matsui H, Suzuki K.
PMID: 41858140 [PubMed - indexed for MEDLINE]
Clinical Validation of the Prostate Health Index for Detecting Clinically Significant Prostate Cancer in a Population-Based Screening Program.
Int J Urol
Yaegashi H, Nakashima K, Miwa S, Miyagi T, Takashima M, Koura T, Ohno H, Kaji K, Ito K, Mizokami A.
PMID: 41858129 [PubMed - indexed for MEDLINE]
Can pelvic lymph node dissection be spared in intermediate-risk prostate cancer patients with negative PSMA PET scan? A systematic review and diagnostic meta-analysis.
Prostate Cancer Prostatic Dis
Wan QC, Min KY, Wei L, Xie LJ, Ji B.
PMID: 41857380 [PubMed - as supplied by publisher]
A prospective head-to-head comparison of (18)F-NYM005 PET/CT and (18)F-FDG PET/CT in diagnosing renal cell carcinoma.
Eur J Nucl Med Mol Imaging
Nie P, Li B, Luo L, Hou F, Zhang N, Yang H, Huang X, Zhu Z, Ma S, Wu T, Xie J, Zhang M, Yang G, Wang Z.
PMID: 41857358 [PubMed - as supplied by publisher]
Articles 1 - 20 / 186500
Page 1 of 9325
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy